Search / Trial NCT06513494

Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial
Launched by HOSPITAL ISRAELITA ALBERT EINSTEIN · Jul 16, 2024

Download PDF

Apply for Trial

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Vaccination Coverage Hpv Vaccine Stepped Wedge Design Students

ClinConnect Summary

This clinical trial is studying how active health education can help more young people get the HPV vaccine, which protects against certain cancers. The trial will take place in 80 schools across Brazil and involve about 5,000 students aged 9 to 14 years old. Researchers will try different educational methods in groups of schools to see which ones work best over time.

To be eligible, students must be between 9 and 14 years old and not have already received both doses of the HPV vaccine. Schools must also have students in this age range and cannot be exclusively offering distance education. Participants can expect to be part of a program that aims to increase awareness and understanding of the HPV vaccine, helping to ensure that more students get vaccinated and protected. This study is important because it could lead to better vaccination rates and ultimately help prevent cancer in the future.

Gender

ALL

Eligibility criteria

• Criteria for students
Inclusion Criteria:
• Students of both sexes aged 9 to 14 years old.
Exclusion Criteria:
• Students with a complete HPV vaccination (two doses) received.
• Criteria for Clusters
Inclusion Criteria:
• The school has enrolled students aged 9 to 14 years old.
Exclusion Criteria:
• Schools that do not have students aged between 9 and 14;
• Schools that provided only distance education

About Hospital Israelita Albert Einstein

Hospital Israelita Albert Einstein is a leading healthcare institution in Brazil, renowned for its commitment to excellence in patient care, education, and research. As a prominent clinical trial sponsor, the hospital emphasizes innovation and scientific advancement, facilitating cutting-edge studies across various medical disciplines. With a state-of-the-art infrastructure and a dedicated team of professionals, Hospital Israelita Albert Einstein fosters collaboration with global research networks to enhance clinical outcomes and contribute to the advancement of medical knowledge. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants.

Locations

Crato, Ceará, Brazil

Juazeiro Do Norte, Ceará, Brazil

Brasília, Distrito Federal, Brazil

Cuiabá, Mato Grosso, Brazil

Várzea Grande, Mato Grosso, Brazil

Couto De Magalhães De Minas, Minas Gerais, Brazil

Diamantina, Minas Gerais, Brazil

Felício Dos Santos, Minas Gerais, Brazil

São Gonçalo Do Rio Preto, Minas Gerais, Brazil

Ponta Grossa, Paraná, Brazil

Augusto Correa, Pará, Brazil

Tracuateua, Pará, Brazil

Natal, Rio Grande Do Norte, Brazil

Boa Vista, Roraima, Brazil

Cantá, Roraima, Brazil

Mucajaí, Roraima, Brazil

Crato, , Brazil

Juazeiro Do Norte, , Brazil

Ponta Grossa, , Brazil

Augusto Correa, , Brazil

Tracuateua, , Brazil

Patients applied

0 patients applied

Trial Officials

Henrique A Fonseca, PhD

Study Chair

Academic Research Organization - Hospital Israelita Albert Einstein

Luiz V Rizzo, PhD

Study Director

Academic Research Organization - Hospital Israelita Albert Einstein

Timeline

First submit

July 16, 2024

Trial launched

March 24, 2025

Trial updated

June 02, 2025

Estimated completion

Not reported

Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial Launched by HOSPITAL ISRAELITA ALBERT EINSTEIN · Jul 16, 2024

Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial
Launched by HOSPITAL ISRAELITA ALBERT EINSTEIN · Jul 16, 2024